ArticleFunctional & integrative genomics2026

MO-IPS suppresses acute myeloid leukemia through metabolic reprogramming and synergizes with anti-PD-1 immunotherapy.

Yingwen Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.